D'Avola, D., Gil-Fariña, I., & Schmidt, M. (2016). Phase I open label liver-directed gene therapy clinical trial for acute intermittent porphyria. Journal of hepatology, 65(4), . https://doi.org/10.1016/j.jhep.2016.05.012
Chicago Style (17th ed.) CitationD'Avola, Delia, Irene Gil-Fariña, and Manfred Schmidt. "Phase I Open Label Liver-directed Gene Therapy Clinical Trial for Acute Intermittent Porphyria." Journal of Hepatology 65, no. 4 (2016). https://doi.org/10.1016/j.jhep.2016.05.012.
MLA (9th ed.) CitationD'Avola, Delia, et al. "Phase I Open Label Liver-directed Gene Therapy Clinical Trial for Acute Intermittent Porphyria." Journal of Hepatology, vol. 65, no. 4, 2016, https://doi.org/10.1016/j.jhep.2016.05.012.
Warning: These citations may not always be 100% accurate.